Q1 EPS Estimate for Blueprint Medicines Reduced by Analyst
Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) – Stock analysts at Wedbush lowered their Q1 2025 earnings estimates for Blueprint Medicines in a research report issued on Wednesday, April 16th. Wedbush analyst D. Nierengarten now forecasts that the biotechnology company will post earnings of ($0.58) per share for the quarter, down from their prior forecast […]
Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) – Stock analysts at Wedbush lowered their Q1 2025 earnings estimates for Blueprint Medicines in a research report issued on Wednesday, April 16th. Wedbush analyst D. Nierengarten now forecasts that the biotechnology company will post earnings of ($0.58) per share for the quarter, down from their prior forecast […]
